Hemorrhage Risk in Moyamoya Disease with Fetal-Type Posterior Cerebral Artery: A Propensity Score-Matched Analysis

Wenjie Li1, Huan Zhu1, Meng Zhao1

  • 1Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China; China National Clinical Research Center for Neurological Diseases, Beijing, China; Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China.

World Neurosurgery
|September 11, 2023
PubMed
Abstract

Insights

Patients with moyamoya disease (MMD) and fetal-type posterior cerebral arteries face a higher risk of hemorrhagic events. This study found increased intracranial hemorrhage in MMD patients with fetal-type posterior cerebral arteries compared to those without.

Area of Science:

  • Neurology
  • Neurosurgery
  • Vascular Neurology

Background:

  • Moyamoya disease (MMD) is a rare cerebrovascular disorder.
  • The association between MMD and fetal-type posterior cerebral arteries (ftPCA) requires further investigation.
  • Intracranial hemorrhage is a significant complication in MMD.

Approach:

  • Retrospective review of 2422 MMD patients diagnosed between 2009 and 2020.
  • Classification into groups based on the presence or absence of ftPCA.
  • 1:1 propensity score matching to compare hemorrhagic tendency and Suzuki stage.

Key Points:

  • 181 out of 2415 patients had ftPCA.
  • Hemorrhagic events were significantly more frequent in patients with ftPCA (28.2%) compared to those without (18.8%).
  • No significant difference in Suzuki stages was observed between the two matched groups.

Conclusions:

  • Patients with MMD and ftPCA exhibit a higher incidence of hemorrhagic events.
  • ftPCA may represent a risk factor for intracranial hemorrhage in MMD patients.
  • Further research is warranted to elucidate the underlying mechanisms.

Related Concept Videos